Plain English Breakdown
The plain English breakdown is still being put together. The official documents below are already here.
Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.
HB0317 • 2007
AN ACT relating to pharmacists; providing that a pharmacist may not substitute an anti-epileptic drug without consent; and providing for an effective date.
The latest official action shows that this bill did not move forward in that session.
The plain English breakdown is still being put together. The official documents below are already here.
Died In Committee
H Introduced and Referred to H10; No Report Prior to CoW Cutoff
H Received for Introduction
Bill Number Assigned
WORKING DRAFT 2007 STATE OF WYOMING 07LSO-0636 HOUSE BILL NO. HB0317 Prescription drug substitution. Sponsored by: Representative(s) Millin, Hallinan and Zwonitzer, Dn. and Senator(s) Hastert and Massie A BILL for AN ACT relating to pharmacists; providing that a pharmacist may not substitute an anti-epileptic drug without consent; and providing for an effective date. Be It Enacted by the Legislature of the State of Wyoming : Section 1. W.S. 33 ‑ 24 ‑ 148(b) and by creating a new subsection (h) is amended to read: 33 ‑ 24 ‑ 148. Conditions for drug substitution. (b) Except as limited by W.S. 33 ‑ 24 ‑ 149(b) and subsection (h) of this section or when the practitioner has clearly indicated substitution is not permitted, a pharmacist may substitute a drug product with the same generic name in the identical strength, quantity, dose and dosage form as the prescribed drug, provided the substituted drug meets all requirements specified in W.S. 33 ‑ 24 ‑ 147(a)(ii). (h) A pharmacist may not substitute an anti-epileptic drug or formulation of an anti-epileptic drug, prescribed for the treatment of seizures, without the written consent of the prescribing physician. Section 2. This act is effective July 1, 2007. (END) 1 HB0317